Literature DB >> 25931623

Successful implementation and results of an HPV vaccination program in Geneva Canton, Switzerland.

Emilien Jeannot1, Patrick Petignat2, Philippe Sudre3.   

Abstract

We describe a human papillomavirus (HPV) vaccination program implemented since 2007 in Geneva Canton, Switzerland, that used school services, a public hospital, and private physicians as vaccination providers. We assessed program performance with the evolution of immunization coverage during the first four years of program implementation. We measured vaccination coverage of the target population using individual records of vaccination status collected by service providers and transmitted to the Geneva Canton Medical Office. The target population was 20,541 adolescent girls aged 11-19 years as of September 1, 2008, who resided in the canton when the program began. As of June 30, 2012, HPV vaccination coverage was 72.6% and 74.8% in targeted cohorts for three and two doses, respectively. The global coverage for three doses increased by 27 percentage points from December 2009 to June 2012. Coverage for girls aged 16-18 years at the beginning of the program reached 80% or more four years into the program. High coverage by this HPV vaccination program in Geneva was likely related to free vaccination and easy access to the vaccine using a combination of delivery services, including school health services, a public hospital, and private physicians, covering most eligible adolescent girls.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25931623      PMCID: PMC4388217          DOI: 10.1177/003335491513000306

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  10 in total

Review 1.  Currently approved prophylactic HPV vaccines.

Authors:  Diane M Harper
Journal:  Expert Rev Vaccines       Date:  2009-12       Impact factor: 5.217

2.  How to improve cervical cancer screening in Switzerland?

Authors:  Patrick Petignat; Sarah Untiet; Pierre Vassilakos
Journal:  Swiss Med Wkly       Date:  2012-08-13       Impact factor: 2.193

3.  HPV vaccination coverage within 3 years of program launching (2008-2011) at Geneva State, Switzerland.

Authors:  Emilien Jeannot; Philippe Sudre; Philippe Chastonay
Journal:  Int J Public Health       Date:  2012-02-28       Impact factor: 3.380

4.  Trends in the incidence of invasive and in situ vulvar carcinoma.

Authors:  Patricia L Judson; Elizabeth B Habermann; Nancy N Baxter; Sara B Durham; Beth A Virnig
Journal:  Obstet Gynecol       Date:  2006-05       Impact factor: 7.661

Review 5.  [Cervical cancer screening: current status and perspectives].

Authors:  P Petignat; C Bouchardy; P Sauthier
Journal:  Rev Med Suisse       Date:  2006-05-17

Review 6.  Human papillomavirus (HPV) vaccines as an option for preventing cervical malignancies: (how) effective and safe?

Authors:  Lucija Tomljenovic; Jean Pierre Spinosa; Christopher A Shaw
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

7.  Results of a vaccination campaign against human papillomavirus in the province of La Spezia, Liguria, Italy, March-December 2008.

Authors:  J Lugarini; F Maddalo
Journal:  Euro Surveill       Date:  2009-10-01

8.  Vaccination against human papillomavirus in Switzerland: simulation of the impact on infection rates.

Authors:  André Berchtold; Pierre-André Michaud; Denise Nardelli-Haefliger; Joan-Carles Surís
Journal:  Int J Public Health       Date:  2009-10-01       Impact factor: 3.380

9.  Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013 - United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-07-26       Impact factor: 17.586

Review 10.  Towards the eradication of HPV infection through universal specific vaccination.

Authors:  Piergiorgio Crosignani; Antonella De Stefani; Gaetano Maria Fara; Andrea M Isidori; Andrea Lenzi; Carlo Antonio Liverani; Alberto Lombardi; Francesco Saverio Mennini; Giorgio Palu'; Sergio Pecorelli; Andrea P Peracino; Carlo Signorelli; Gian Vincenzo Zuccotti
Journal:  BMC Public Health       Date:  2013-07-11       Impact factor: 3.295

  10 in total
  3 in total

1.  Worldwide initiatives to eliminate cervical cancer.

Authors:  Sarikapan Wilailak; Malika Kengsakul; Sean Kehoe
Journal:  Int J Gynaecol Obstet       Date:  2021-10       Impact factor: 4.447

2.  Prevalence of Vaccine Type Infections in Vaccinated and Non-Vaccinated Young Women: HPV-IMPACT, a Self-Sampling Study.

Authors:  Emilien Jeannot; Manuella Viviano; Charlotte de Pree; Mona Amadane; Emmanuel Kabengele; Pierre Vassilakos; Patrick Petignat
Journal:  Int J Environ Res Public Health       Date:  2018-07-09       Impact factor: 3.390

3.  Characteristics of HPV-unvaccinated undergraduate health students in Switzerland, a cross sectional study.

Authors:  Mona Amadane; Charlotte de Pree; Manuela Viviano; Pierre Vassilakos; Emilien Jeannot; Patrick Petignat
Journal:  Arch Public Health       Date:  2019-06-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.